Godavari Biorefineries

Godavari Biorefineries share rally sharply 10% after secures bagging European patent for novel Anti-Cancer compounds

Godavari Biorefineries secures European patent for novel Anti-Cancer compounds

Godavari Biorefineries share hits 5% upper circuit after securing China patent for 5-Hydroxy-1,4-Naphthalenedione

Godavari Biorefineries’ anti-cancer patent validated across key European markets

Godavari Biorefineries share hits 5% upper circuit on Europe patent win for novel anti-cancer molecule

Godavari Biorefineries secures European patent for novel anti-cancer molecule

Godavari Biorefineries secures exclusive license agreement with Catalyxx Inc

The agreement enables GBL to produce up to 30,000 tons annually, with the first phase focusing on a facility capable of producing 15,000 metric tons.

Godavari Biorefineries IPO opens on October 23: Know GMP, Price Band, IPO Size and more

Godavari Biorefineries IPO: Price band set at ₹334-₹352 per share